## AVY: Avery Dennison Corporation - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 0.0% below STRENGTH zone (3.0-6.0%); PEG 1.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($177.13)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Valley National Advisers Inc. Sells 8,592 Shares of Avery Dennison Corporation $AVY**
- Source: MarketBeat | 20251229T113203 | Somewhat-Bullish | Relevance: 98%
- Valley National Advisers Inc. significantly reduced its stake in Avery Dennison Corporation, selling 8,592 shares, which cut their holding by 94.8% to 469 shares valued at $76,000. Despite this, institutional investors collectively own 94.17% of AVY, and analysts rate the stock a "Moderate Buy" with a consensus target price of $200.55. Avery Dennison also reported strong Q3 earnings, beating EPS estimates, and declared a quarterly dividend of $0.94.

**2. Is Now The Time To Look At Buying Avery Dennison Corporation (NYSE:AVY)?**
- Source: Simply Wall Street | 20251228T121256 | Somewhat-Bullish | Relevance: 97%
- Avery Dennison Corporation (NYSE:AVY) has seen a double-digit share price rise recently, nearing yearly highs. The analysis suggests its stock is fairly valued compared to industry peers based on its P/E ratio, and while not currently a bargain, its high beta offers potential future buying opportunities. The company also shows an optimistic future outlook with expected earnings growth of 34% over the next few years.

**3. Is Now The Time To Look At Buying Avery Dennison Corporation (NYSE:AVY)?**
- Source: Simply Wall Street | 20251228T120754 | Somewhat-Bullish | Relevance: 97%
- Avery Dennison Corporation (NYSE:AVY) has seen a significant share price rise and is nearing yearly highs. The stock appears reasonably priced according to Simply Wall St's price multiple model, trading slightly below industry peers. With optimistic earnings growth expected of 34% in the coming years, the future outlook for Avery Dennison is positive, though its current valuation factors in much of this growth.

**4. Boston Trust Walden Corp Has $46.14 Million Stock Holdings in Avery Dennison Corporation $AVY**
- Source: MarketBeat | 20251230T100153 | Somewhat-Bullish | Relevance: 95%
- Boston Trust Walden Corp reduced its stake in Avery Dennison Corporation by 7.8% in the third quarter, holding shares valued at $46.14 million. Other institutional investors have either increased or initiated positions in the company, with 94.17% of the stock owned by institutional investors and hedge funds. Analysts have given Avery Dennison an average rating of "Moderate Buy" with a consensus price target of $200.55.

**5. Amcor (NYSE:AMCR) - Stock Analysis**
- Source: Simply Wall Street | 20251228T230737 | Neutral | Relevance: 57%
- This report provides a comprehensive stock analysis of Amcor (NYSE: AMCR), a global leader in packaging products. It covers financial performance, growth forecasts, valuation, dividend information, and recent news, highlighting that the stock currently trades below its estimated fair value.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.4% (+3.6%)
- Blackrock Inc.: 8.2% (-4.6%)
- Wellington Managemen: 7.5% (+12.5%)
- State Street Corpora: 4.7% (+0.6%)
- T. Rowe Price Invest: 4.3% (-7.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.76 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 30%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $14.2B |
| Beta | 1.01 |
| 52W Range | $156.23 - $196.41 |
| Short Interest | 3.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.76 |
| Forward P/E | 17.4 |
| Current P/E | 19.3 |
| YoY Growth | 10.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.6% to -0.0% (+1.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.0pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.00% (CS: 60) | Neutral |
| RSI_14 | 62.4 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 1.018x | Above |
| vs SMA50 | 1.041x | Above |
| vs SMA200 | 1.055x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $183.17
- **Stop Loss:** $177.13 (3.3% risk)
- **Target:** $189.21 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 182
- **Position Value:** $33,336.94
- **Portfolio %:** 33.34%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-29 (Est: $2.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.33 | $2.37 | +1.9% |
| 2025Q2 | $2.39 | $2.42 | +1.1% |
| 2025Q1 | $2.32 | $2.30 | -0.7% |
| 2024Q4 | $2.41 | $2.38 | -1.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*